TIMOLOL SOLUTION - 0.25% .25 %
TIMOLOL MALEATE : .25 % · DIN 02147475 · BDH INC.
Health Canada status: CANCELLED POST MARKET
What is TIMOLOL SOLUTION - 0.25%?
TIMOLOL SOLUTION - 0.25% .25 % contains TIMOLOL MALEATE : .25 %. It is listed in the Health Canada Drug Product Database under DIN 02147475, held by BDH INC., supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is TIMOLOL SOLUTION - 0.25% called?
The same molecule, TIMOLOL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Timoptol | Latin | Australia, Morocco |
| XALACOM | Latin | Czechia, Slovakia |
| Brinzolamid/timolol Olikla | Latin | Czechia, Slovakia |
| CUSIMOLOL | Latin | Morocco |
| FIXAPOST | Latin | Czechia |
| TIMOEYE | Latin | Australia |
| Timoptol XE | Latin | Australia |
| AKISTAN DUO | Latin | Czechia |
| AZARGA | Latin | Czechia |
| BIMATOPROST/TIMOLOL OLIKLA | Latin | Czechia |
| BRIMONIDIN/TIMOLOL OLIKLA | Latin | Czechia |
| COMBIGAN | Latin | Czechia, Slovakia |
| COSOPT | Latin | Czechia |
| COSOPT BEZ KONZERVA�N�CH P��SAD | Latin | Czechia |
| DORZOGEN COMBI | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02147475 |
|---|---|
| Brand name | TIMOLOL SOLUTION - 0.25% |
| Generic / active ingredient | TIMOLOL MALEATE : .25 % |
| Manufacturer | BDH INC. |
| Strength | .25 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01ED01 TIMOLOL |
| AHFS class | 52:92.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Aug-2000 |
| Original market date | 1998-10-13 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02147475 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2147475 |
| Brand name | TIMOLOL SOLUTION - 0.25% |
| Active ingredient / INN | TIMOLOL MALEATE : .25 % |
| ATC code | S01ED01 |
| ATC anatomical main group | S — Sensory organs |
| ATC therapeutic subgroup | S01 |
| AHFS class | 52:92.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BDH INC. |
Which pack is which?
| Strength on the label | .25 % |
|---|---|
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is TIMOLOL in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01ED01 TIMOLOL. 7 of 35 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP-TIMOLOL | 0.5 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02447800 |
| SANDOZ TIMOLOL | 0.25 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02166712 |
| SANDOZ TIMOLOL | 0.5 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02166720 |
| TIMOLOL MALEATE-EX | 0.25 % | SOLUTION (EXTENDED RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02242275 |
| TIMOLOL MALEATE-EX | 0.5 % | SOLUTION (EXTENDED RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02242276 |
| TIMOPTIC | 0.5 % | SOLUTION | ELVIUM LIFE SCIENCES | MARKETED | DIN 00451207 |
| TIMOPTIC-XE | 0.5 % | SOLUTION (EXTENDED RELEASE) | ELVIUM LIFE SCIENCES | MARKETED | DIN 02171899 |
| APO-TIMOP | 0.25 % | SOLUTION | APOTEX INC | DORMANT | DIN 00755826 |
| APO-TIMOP | 0.5 % | SOLUTION | APOTEX INC | DORMANT | DIN 00755834 |
| APO-TIMOP GEL | 0.25 % | SOLUTION (EXTENDED RELEASE) | APOTEX INC | APPROVED | DIN 02315858 |
Who else supplies TIMOLOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TIMOLOL appears in 178 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does TIMOLOL cost around the world?
TIMOLOL is listed on 14 national price registers Nexara tracks, across 243 pack listings published on 13 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 8 | 62 | 03 Sep 2026 |
| Czechia | max producer price (ex-factory) | 28 | 45 | 03 Sep 2026 |
| Slovakia | categorised final price | 14 | 23 | 02 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 22 | 22 | 03 Sep 2026 |
| Belgium | public | 18 | 18 | 01 Sep 2026 |
| Luxembourg | reimbursement | 17 | 17 | 05 Sep 2026 |
| Morocco | PPV (public price) | 8 | 17 | 05 Sep 2026 |
| Australia | ex-manufacturer | 3 | 9 | 08 Sep 2026 |
| South Africa | single exit price | 8 | 8 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 7 | 7 | 03 Sep 2026 |
| United Kingdom | hospital | 5 | 5 | 31 Aug 2026 |
| Spain | PVP con IVA (public price) | 4 | 4 | 05 Sep 2026 |
| Romania | max producer price | 4 | 4 | 03 Sep 2026 |
| Hungary | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.